Sea Mild Biotechnology Co., Ltd.(TW:7516)
NT$7.65+0.02 (+0.26%)
TW:7516
Sea Mild Biotechnology Co., Ltd. Revenue
NT$7.65
At close:+0.02 (+0.26%)
Sea Mild Biotechnology Co., Ltd. (7516) Revenue
Sea Mild Biotechnology Co., Ltd. Revenue
Sea Mild Biotechnology Co., Ltd. had a revenue of 196.02M in the quarter ending Jun 30, 2026, with 11.16%. This bring the company's revenue in the last twelve months to 372.36M, Increased 8.90%. In the fiscal year ending Dec 31, 2025, Sea Mild Biotechnology Co., Ltd. had annual revenue of 341.94M with 7.25% growth.
- Revenue (ttm)
- 372.36M
- Revenue Growth
- 6.86%
- P/S Ratio
- 0.43
- Revenue/Employee
- TWD 5,795,508
- Employees
- 59
- Market Cap
- TWD 147.33M
Revenue Chart
Sea Mild Biotechnology Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 341.94M | 23.11M | 7.25% |
| Dec 31, 2024 | 318.82M | 61.80M | 24.05% |
| Dec 31, 2023 | 257.02M | 54.37M | 26.83% |
| Dec 31, 2022 | 202.65M | 38.83M | 23.71% |
| Dec 31, 2021 | 163.82M | -44.06M | -21.20% |
| Dec 31, 2020 | 207.88M | -6.26M | -2.92% |
| Dec 31, 2019 | 214.14M | -931.00K | -0.43% |
| Dec 31, 2018 | 215.07M | 46.82M | 27.83% |
| Dec 31, 2017 | 168.25M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.